We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-9.40 | -3.30% | 275.60 | 274.60 | 275.00 | 282.20 | 272.40 | 279.40 | 17,911,267 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 43.99 | 5.74B |
TIDMCTEC
RNS Number : 9695X
ConvaTec Group PLC
07 May 2021
ConvaTec Group Plc
Results of Annual General Meeting
Reading, United Kingdom 7 May 2021 - Poll Result
ConvaTec Group Plc ("ConvaTec") held its annual general meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below:
For Against Total Votes % of Number (see note 2) (see note 2) cast ISC Voted of Votes Withheld (see note 3) Resolution No of shares % No of shares % -------------- ------- ------------- ----- Receive Annual Report and 1 Accounts 1,744,608,352 99.96 777,616 0.04 1,745,385,968 87.08% 1,480,001 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Approve the Directors' Remuneration 2 Report 1,698,130,077 97.23 48,413,492 2.77 1,746,543,569 87.14% 322,400 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Declare Final 3 Dividend 1,740,839,314 99.66 5,915,934 0.34 1,746,755,248 87.15% 110,721 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect John McAdam as a 4 director 1,726,805,777 98.88 19,520,971 1.12 1,746,326,748 87.13% 539,221 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Karim Bitar as a 5 director 1,745,847,330 99.95 907,151 0.05 1,746,754,481 87.15% 111,488 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Frank Schulkes as 6 a director 1,739,573,569 99.59 7,176,168 0.41 1,746,749,737 87.15% 116,232 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Margaret Ewing as a 7 director 1,735,171,507 99.34 11,573,127 0.66 1,746,744,634 87.15% 121,335 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Brian 8 May as a director 1,726,852,048 98.86 19,898,392 1.14 1,746,750,440 87.15% 115,529 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Rick Anderson as 9 a director 1,732,922,453 99.21 13,822,181 0.79 1,746,744,634 87.15% 121,335 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Regina Benjamin as 10 a director 1,733,824,898 99.26 12,925,036 0.74 1,746,749,934 87.15% 116,035 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-elect Sten Scheibye as 11 a director 1,745,567,146 99.93 1,187,335 0.07 1,746,754,481 87.15% 111,488 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Elect Heather Mason as a 12 director 1,744,886,278 99.89 1,863,459 0.11 1,746,749,737 87.15% 116,232 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Elect Constantin Coussios as 13 a director 1,744,393,943 99.87 2,356,497 0.13 1,746,750,440 87.15% 115,529 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Re-appoint Deloitte LLP 14 as auditor 1,746,633,262 99.99 118,345 0.01 1,746,751,607 87.15% 114,362 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Authorise the directors to determine the remuneration of the Company's 15 auditor 1,746,753,488 100.00 433 0.00 1,746,753,921 87.15% 112,048 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Authorise political donations and 16 political expenditure 1,721,717,493 98.58 24,812,022 1.42 1,746,529,515 87.14% 336,454 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Authorise allotment 17 of shares 1,623,589,106 92.97 122,709,426 7.03 1,746,298,532 87.13% 567,437 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Disapply pre-emption 18 rights* 1,736,680,253 99.45 9,522,182 0.55 1,746,202,435 87.12% 663,534 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Disapply pre-emption rights in connection with an acquisition or specified 19 capital investment* 1,691,979,685 96.87 54,580,936 3.13 1,746,560,621 87.14% 305,348 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Authorise purchase 20 of own shares* 1,741,411,621 99.75 4,350,959 0.25 1,745,762,580 87.10% 1,103,389 ----------------------- -------------- ------- ------------- ----- -------------- ----------- ----------- Call general meetings on 21 14 days' notice* 1,657,330,730 94.88 89,418,003 5.12 1,746,748,733 87.15% 117,236 ----------------------- -------------- ------- ------------- ----- -------------- ----------- -----------
*Special Resolution
NOTES:
1. All resolutions were passed. 2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at close of business on 5 May 2021 was 2,004,347,138 shares; 87.15% of voting capital was instructed.
5. Computershare acted as scrutineer of the poll on all resolutions.
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com
Enquiries
Analysts and Investors
Kate Postans, Vice President Investor Relations, ConvaTec +44 (0)7826 447 807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
# # #
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGUBSORAOUVRAR
(END) Dow Jones Newswires
May 07, 2021 09:50 ET (13:50 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions